Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
Ligand Pharma (LGND) Ownership - Who Owns Ligand Pharma?
701 Followers
Ligand Pharma (LGND) Ownership Overview
The ownership structure of Ligand Pharma (LGND) stock is a mix of institutional, retail and individual investors. Approximately 82.12% of the company’s stock is owned by Institutional Investors, 13.15% is owned by Insiders and 4.74% is owned by Public Companies and Individual Investors.
13.15% Insiders
35.07% Mutual Funds
47.04% Other Institutional Investors
4.74% Public Companies and
Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 25, 2023 | Todd Davis Ceo,director | Bought | $237520 |
| May 18, 2023 | John Kozarich Director | Sold | $343077 |
| May 12, 2023 | Stephen Sabba Director | Sold | $494185 |
| May 10, 2023 | John Kozarich Director | Sold | $490618 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Sold | $448381 | |
| Sep 30, 2023 | Bought | $761643 | |
| Sep 30, 2023 | Sold | $1993059 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,164,585.00 | Institution | 12.41% | 125,610,867.55 | |
| 1,671,976.00 | Institution | 9.59% | 97,024,767.28 | |
| 1,446,709.00 | Institution | 8.30% | 83,952,523.27 | |
| 1,265,918.00 | Insider | 7.26% | 73,461,221.54 | |
| 1,229,247.00 | Institution | 7.05% | 71,333,203.41 | |
| 648,060.00 | Institution | 3.72% | 37,606,921.80 | |
| 417,695.00 | Insider | 2.40% | 24,238,840.85 | |
| 332,465.00 | Institution | 1.91% | 19,292,943.95 | |
| 284,756.00 | Institution | 1.63% | 16,524,390.68 | |
| 275,414.00 | Institution | 1.58% | 15,982,274.42 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,446,709.00 | Institution | 8.30% | 83,952,523.27 | |
| 1,229,247.00 | Institution | 7.05% | 71,333,203.41 | |
| 648,060.00 | Institution | 3.72% | 37,606,921.80 | |
| 332,465.00 | Institution | 1.91% | 19,292,943.95 | |
| 222,433.00 | Institution | 1.28% | 12,907,786.99 | |
| 184,320.00 | Institution | 1.06% | 10,696,089.60 | |
| 162,789.00 | Institution | 0.93% | 9,446,645.67 | |
| 156,301.00 | Institution | 0.90% | 9,070,147.03 | |
| 135,482.00 | Institution | 0.78% | 7,862,020.46 | |
| 132,378.00 | Institution | 0.76% | 7,681,895.34 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,093,659.00 | Institution | 6.27% | 63,060,377.94 | |
| 495,497.00 | Institution | 2.84% | 25,909,538.00 | |
| 405,407.00 | Institution | 2.33% | 23,375,767.62 | |
| 426,327.00 | Institution | 2.45% | 22,292,639.00 | |
| 275,062.00 | Institution | 1.58% | 15,961,847.86 | |
| 297,081.00 | Institution | 1.70% | 15,534,365.00 | |
| 234,074.00 | Institution | 1.34% | 12,239,729.00 | |
| 145,785.00 | Institution | 0.84% | 8,405,963.10 | |
| 135,784.00 | Institution | 0.78% | 7,879,545.52 | |
| 132,249.00 | Institution | 0.76% | 7,625,477.34 |
FAQ
Who Owns Ligand Pharma (LGND)?
According to the latest TipRanks data, approximately 47.04% of the company's stock is held by institutional investors, 13.15% is held by insiders, and 4.74% is held by retail investors.
What percentage of Ligand Pharma (LGND) stock is held by institutional investors?
According to the latest TipRanks data, approximately 47.04% of Ligand Pharma (LGND) stock is held by institutional investors.
What percentage of Ligand Pharma (LGND) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.74% of Ligand Pharma (LGND) stock is held by retail investors.
Who owns the most shares of Ligand Pharma (LGND)?
iShares owns the most shares of Ligand Pharma (LGND).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.